A monoclonal antibody that is being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Matuzumab binds to the epithelial growth factor receptor (EGFR) on tumor cells and blocks growth signals. Also called EMD 72000.